Mealey's (October 17, 2016, 1:00 PM EDT) -- BOSTON — GlaxoSmithKline LLC (GSK) on Oct. 13 asked the Zofran birth defect multidistrict litigation court to dismiss 27 cases in which plaintiffs allege injuries from taking one of the drug’s generic versions (In Re: Zofran [Ondansetron] Products Liability Litigation, MDL Docket No. 2657, No. 15-md-2657, D. Mass.)....